Agenus | AGEN - Trade Debtors


Agenus reported $22.44M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Celldex Therapeutics USD 230K 1.78M Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Intrexon USD 1.02M 559K Jun/2024
J&J USD 21.33B 3.72B Dec/2025
Jiangsu Hengrui CNY 6.51B 569.71M Mar/2026
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Merck EUR 4.81B 373M Mar/2026
Merck USD 11.78B 345M Dec/2025
Northwest Biotherapeutics USD 311K 299K Sep/2025
Novartis USD 9.6B 2.69B Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Veracyte USD 50.11M 5.45M Mar/2026